Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4943)
All Articles published online
|
Publishing Process of This Article
|
May 10, 2014 (publication date) through Jun 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ghanem T, Bracken J, Kasem A, Jiang WG, Mokbel K. mRNA expression of DOK1-6 in human breast cancer. World J Clin Oncol 2014; 5(2): 156-163 [PMID: 24829863 DOI: 10.5306/wjco.v5.i2.156] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i2/156.htm |
| Number | Citing Articles |
| 1 |
Isabella Maria Dias Payão Ortiz, Mateus Camargo Barros-Filho, Mariana Bisarro dos Reis, Caroline Moraes Beltrami, Fabio Albuquerque Marchi, Hellen Kuasne, Luísa Matos do Canto, Julia Bette Homem de Mello, Cecilie Abildgaard, Clóvis Antônio Lopes Pinto, Luiz Paulo Kowalski, Silvia Regina Rogatto. Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma. Clinical Epigenetics 2018; 10(1) doi: 10.1186/s13148-018-0579-8
|
| 2 |
Xiaojun Ding, Wenjie Wang, Min Wang, Jiao Wu, Feng Yao. DOK1/PPARgamma pathway mediates anti-tumor ability of all-trans retinoic acid in breast cancer MCF-7 cells. Biochemical and Biophysical Research Communications 2017; 487(2): 189 doi: 10.1016/j.bbrc.2017.04.018
|
| 3 |
Mingzhe Wang, Guoxing Liu, Yao Xiao, Zhe Cai, Chang Liu, Lin Pan, Ying Liu, Mengchao Liu, Hongchun Zhang. Proteomic analysis of a chronic obstructive pulmonary disease mouse model to determine the efficacy of treatment using Guben Zhike decoction. Journal of Traditional Chinese Medical Sciences 2021; 8(1): 34 doi: 10.1016/j.jtcms.2021.01.006
|
| 4 |
Ravindran Vini, Asha Lekshmi, Swathy Ravindran, Jissa Vinoda Thulaseedharan, Kunjuraman Sujathan, Arumugam Rajavelu, Sreeharshan Sreeja. 27‐Hydroxycholesterol represses G9a expression via oestrogen receptor alpha in breast cancer. Journal of Cellular and Molecular Medicine 2023; 27(18): 2744 doi: 10.1111/jcmm.17882
|
| 5 |
Emilie Coppin, Maria De Grandis, Pier Paolo Pandolfi, Marie-Laure Arcangeli, Michel Aurrand-Lions, Jacques A. Nunès. Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells. The Journal of Immunology 2016; 196(10): 4110 doi: 10.4049/jimmunol.1501037
|
| 6 |
Esin Tuna, Yeliz Emine Ersoy, Pelin Bulut, Filiz Ozdemir, Nur Buyru. Analysis of the DOK1 gene in breast cancer. Molecular Biology Reports 2020; 47(3): 1605 doi: 10.1007/s11033-020-05247-3
|
| 7 |
P SUN, R LI, Y MENG, S XI, Q WANG, X YANG, X PENG, J CAI. Introduction to DOK2 and its Potential Role in Cancer. Physiological Research 2021; : 671 doi: 10.33549/physiolres.934710
|
| 8 |
Pin‐Fang He, Zi‐Jun Xu, Jing‐Dong Zhou, Xi‐Xi Li, Wei Zhang, De‐Hong Wu, Zhi‐Hui Zhang, Xin‐Yue Lian, Xin‐Yu Yao, Zhao‐Qun Deng, Jiang Lin, Jun Qian. Methylation‐associated DOK1 and DOK2 down‐regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia. Journal of Cellular Physiology 2018; 233(9): 6604 doi: 10.1002/jcp.26271
|
| 9 |
Yusri Dwi Heryanto, Seiya Imoto. The transcriptome signature analysis of the epithelial-mesenchymal transition and immune cell infiltration in colon adenocarcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-45792-y
|
| 10 |
Changli Yue, Yuping Bai, Yingshi Piao, Honggang Liu, Cristina Magi-Galluzzi. DOK7 Inhibits Cell Proliferation, Migration, and Invasion of Breast Cancer via the PI3K/PTEN/AKT Pathway. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/4035257
|
| 11 |
Huy Vuong, Feixiong Cheng, Chen-Ching Lin, Zhongming Zhao. Functional consequences of somatic mutations in cancer using protein pocket-based prioritization approach. Genome Medicine 2014; 6(10) doi: 10.1186/s13073-014-0081-7
|
| 12 |
Guo‐Kang Sun, Li‐Juan Tang, Jing‐Dong Zhou, Zi‐Jun Xu, Lan Yang, Qian Yuan, Ji‐Chun Ma, Xing‐Hui Liu, Jiang Lin, Jun Qian, Dong‐Ming Yao. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia. Cancer Medicine 2019; 8(14): 6393 doi: 10.1002/cam4.2540
|
| 13 |
Zhan-yu Xu, Mengli Zhao, Wenjie Chen, Kun Li, Fanglu Qin, Wei-wei Xiang, Yu Sun, Jiangbo Wei, Li-qiang Yuan, Shi-kang Li, Sheng-hua Lin. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma. PeerJ 2020; 8: e9530 doi: 10.7717/peerj.9530
|
| 14 |
Yongjun Guan, Man Li, Zhendong Qiu, Junhui Xu, Yichao Zhang, Ning Hu, Xuanzhe Zhang, Wenyi Guo, Jingping Yuan, Qiao Shi, Weixing Wang. Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors. Journal of Advanced Research 2022; 36: 73 doi: 10.1016/j.jare.2021.06.008
|